Zobrazeno 1 - 7
of 7
pro vyhledávání: '"EA Bij de Vaate"'
Autor:
N Roescher, JM Prins, JTM van der Meer, HI Bax, R Soetekouw, MGJ de Boer, LBS Gelinck, JJ Oosterheert, MA van Agtmael, M Berrevoets, DTP Buis, CH van Werkhoven, MJM Bonten, JE Bosmans, J Branger, S Douiyeb, E Jong, AJJ Lammers, E Sieswerda, JE Stalenhoef, TW Van der Vaart, EA Bij de Vaate, NJ Verkaik, MGA Van Vonderen, PJ De Vries, KCE Sigaloff, E Botman, A Van den Broek, L Buitenhuis, E Buitenwerf, A S Cents, N Engels, J L J Hanssen, A J Meinders, F P N Mollema, L Nagelmaker, M L M van Doorn-Schepens, P Thomopoulos, M Timmer, B van der Wiel
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Introduction A major knowledge gap in the treatment of complicated Staphylococcus aureus bacteraemia (SAB) is the optimal duration of antibiotic therapy. Safe shortening of antibiotic therapy has the potential to reduce adverse drug events, length of
Externí odkaz:
https://doaj.org/article/cf2fa20a75a4412a9dbd8b21a6ce2c68
Autor:
DTP Buis, CH van Werkhoven, MA van Agtmael, HI Bax, M Berrevoets, MGJ de Boer, MJM Bonten, JE Bosmans, J Branger, S Douiyeb, LBS Gelinck, E Jong, AJJ Lammers, JTM Van der Meer, JJ Oosterheert, E Sieswerda, R Soetekouw, JE Stalenhoef, TW Van der Vaart, EA Bij de Vaate, NJ Verkaik, MGA Van Vonderen, PJ De Vries, JM Prins, KCE Sigaloff
Publikováno v:
BMJ open, 13(4):e068295. BMJ Publishing Group
BMJ Open, 13(4):e068295, 1-26. BMJ Publishing Group
Collaborators SAFE-trial study group 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. e068295 . https://doi.org/10.1136/bmjopen-2022-068295
BMJ Open, 13(4). BMJ Publishing Group
BMJ Open, 13(4):e068295. BMJ Publishing Group
Buis, D T P, Van Werkhoven, C H, Van Agtmael, M A, Bax, H I, Berrevoets, M, De Boer, M G J, Bonten, M J M, Bosmans, J E, Branger, J, Douiyeb, S, Gelinck, L B S, Jong, E, Lammers, A J J, Van Der Meer, J T M, Oosterheert, J J, Sieswerda, E, Soetekouw, R, Stalenhoef, J E, Van Der Vaart, T W, Bij De Vaate, E A, Verkaik, N J, Van Vonderen, M G A, De Vries, P J, Prins, J M & Sigaloff, K C E 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : Protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. 1-26 . https://doi.org/10.1136/bmjopen-2022-068295
BMJ Open, 13(4):e068295, 1-26. BMJ Publishing Group
Collaborators SAFE-trial study group 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. e068295 . https://doi.org/10.1136/bmjopen-2022-068295
BMJ Open, 13(4). BMJ Publishing Group
BMJ Open, 13(4):e068295. BMJ Publishing Group
Buis, D T P, Van Werkhoven, C H, Van Agtmael, M A, Bax, H I, Berrevoets, M, De Boer, M G J, Bonten, M J M, Bosmans, J E, Branger, J, Douiyeb, S, Gelinck, L B S, Jong, E, Lammers, A J J, Van Der Meer, J T M, Oosterheert, J J, Sieswerda, E, Soetekouw, R, Stalenhoef, J E, Van Der Vaart, T W, Bij De Vaate, E A, Verkaik, N J, Van Vonderen, M G A, De Vries, P J, Prins, J M & Sigaloff, K C E 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : Protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. 1-26 . https://doi.org/10.1136/bmjopen-2022-068295
IntroductionA major knowledge gap in the treatment of complicatedStaphylococcus aureusbacteraemia (SAB) is the optimal duration of antibiotic therapy. Safe shortening of antibiotic therapy has the potential to reduce adverse drug events, length of ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af21151bb8a9b51016d71c3255ece501
https://pure.amc.nl/en/publications/safe-shortening-of-antibiotic-treatment-duration-for-complicated-staphylococcus-aureus-bacteraemia-safe-trial(7669693a-f906-448b-b63f-7135141cbf37).html
https://pure.amc.nl/en/publications/safe-shortening-of-antibiotic-treatment-duration-for-complicated-staphylococcus-aureus-bacteraemia-safe-trial(7669693a-f906-448b-b63f-7135141cbf37).html
Autor:
Buis D; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands d.t.p.buis@amsterdamumc.nl., van Werkhoven CH; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands., van Agtmael MA; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Bax HI; Department of Internal Medicine, Section of Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands., Berrevoets M; Department of Internal Medicine, Elisabeth twee-steden Hospital, Tilburg, The Netherlands., de Boer M; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Bonten M; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands., Bosmans JE; Department of Health Sciences, Faculty of Science, Amsterdam Public Health research institute, VU University Amsterdam, Amsterdam, The Netherlands., Branger J; Department of Internal Medicine, Flevohospital, Almere, The Netherlands., Douiyeb S; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Gelinck L; Department of Internal Medicine, Haaglanden Medisch Centrum, Den Haag, The Netherlands., Jong E; Department of Internal Medicine, Meander Medisch Centrum, Amersfoort, The Netherlands., Lammers A; Department of Internal medicine & Infectious Diseases, Isala Zwolle, Zwolle, The Netherlands., Van der Meer J; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Oosterheert JJ; Department of Internal Medicine, Infectious Diseases, UMC Utrecht, Utrecht, The Netherlands., Sieswerda E; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands., Soetekouw R; Department of Internal Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, The Netherlands., Stalenhoef JE; Department of Internal Medicine, OLVG, Amsterdam, The Netherlands., Van der Vaart TW; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Bij de Vaate EA; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands., Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands., Van Vonderen M; Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands., De Vries PJ; Department of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands., Prins JM; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Sigaloff K; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.
Publikováno v:
BMJ open [BMJ Open] 2023 Apr 21; Vol. 13 (4), pp. e068295. Date of Electronic Publication: 2023 Apr 21.
Autor:
de Graaf JA; Department of Neurology, Zuwe Hofpoort Hospital, Woerden, The Netherlands., Reimerink JH, Voorn GP, Bij de Vaate EA, de Vries A, Rockx B, Schuitemaker A, Hira V
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2016 Aug 18; Vol. 21 (33).
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2016; Vol. 160, pp. D282.
Autor:
Vleggaar FP; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, The Netherlands. f.vleggaar@umcutrecht.nl, Bij de Vaate EA, Valk GD, Leguit RJ, Siersema PD
Publikováno v:
Endoscopy [Endoscopy] 2011; Vol. 43 Suppl 2 UCTN, pp. E328-9. Date of Electronic Publication: 2011 Oct 21.
Autor:
van den Bosch J; Afd. Geneeskundige Oncologie, Academisch Ziekenhuis Vrije Universiteit, Amsterdam., Netelenbos JC, bij de Vaate EA, Comans EF, Giaccone G
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2000 Nov 18; Vol. 144 (47), pp. 2251-6.